MLTX — MOONLAKE IMMUNOTHERAPEUTICS

Ownership history in First Turn Management, LLC  ·  3 quarters on record

This page tracks every 13F SEC filing in which First Turn Management, LLC reported a position in MOONLAKE IMMUNOTHERAPEUTICS (MLTX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.41% (2025 Q1)
Avg. % of fund
0.7%
First filed
2025 Q1
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 UNCHANGED 262,643 — 0% 0.40% $3.5M $13.18
2025 Q3 ADDED 262,643 +83,447 +46.6% 0.28% $1.9M $7.17
2025 Q1 INITIATED 179,196 — — 1.41% $7.0M $39.07
% of Fund (quarterly)    MLTX price (monthly, adj. close)

Other funds also holding MLTX

As of 2025 Q4 — sorted by position size

BVF INC/IL 3Y 7Y 8.76% Lion Point Capital, LP 3Y 7Y 4.6% Cormorant Asset Management, LP 3Y 7Y 2.65% Logos Global Management LP 3Y 1.39% Deep Track Capital, LP 3Y 1.08% Vivo Capital, LLC 3Y 7Y 0.85% STEMPOINT CAPITAL LP 0.79% Eagle Health Investments LP 3Y 0.54% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 0.53% Rhenman & Partners Asset Management AB 3Y 7Y 0.45%
← Back to First Turn Management, LLC Holdings